CH586182A5 - - Google Patents

Info

Publication number
CH586182A5
CH586182A5 CH524572A CH524572A CH586182A5 CH 586182 A5 CH586182 A5 CH 586182A5 CH 524572 A CH524572 A CH 524572A CH 524572 A CH524572 A CH 524572A CH 586182 A5 CH586182 A5 CH 586182A5
Authority
CH
Switzerland
Application number
CH524572A
Original Assignee
Acf Chemiefarma Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acf Chemiefarma Nv filed Critical Acf Chemiefarma Nv
Publication of CH586182A5 publication Critical patent/CH586182A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/26Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CH524572A 1971-04-09 1972-04-10 CH586182A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7104839.A NL167151C (nl) 1971-04-09 1971-04-09 Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen.

Publications (1)

Publication Number Publication Date
CH586182A5 true CH586182A5 (en:Method) 1977-03-31

Family

ID=19812895

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1324975A CH575372A5 (en:Method) 1971-04-09 1972-04-10
CH524572A CH586182A5 (en:Method) 1971-04-09 1972-04-10

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1324975A CH575372A5 (en:Method) 1971-04-09 1972-04-10

Country Status (19)

Country Link
US (1) US3884906A (en:Method)
JP (2) JPS5525177B1 (en:Method)
AR (2) AR194587A1 (en:Method)
AU (1) AU459272B2 (en:Method)
BE (1) BE781674A (en:Method)
CH (2) CH575372A5 (en:Method)
DE (1) DE2215409C3 (en:Method)
DK (1) DK143227C (en:Method)
ES (1) ES401501A1 (en:Method)
FR (1) FR2132788B1 (en:Method)
GB (1) GB1346266A (en:Method)
HU (1) HU165790B (en:Method)
IE (1) IE36209B1 (en:Method)
IL (1) IL39108A (en:Method)
NL (1) NL167151C (en:Method)
PH (2) PH15268A (en:Method)
SE (1) SE389331B (en:Method)
SU (1) SU580828A3 (en:Method)
ZA (1) ZA722331B (en:Method)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4101678A (en) * 1977-11-08 1980-05-01 Ici Australia Ltd Process for killing parasites
FR2549476B1 (fr) * 1983-07-20 1986-04-25 Rech Ind Benzyl-phenyl-osides, procede de preparation et utilisation en therapeutique
US6403652B1 (en) 2000-06-30 2002-06-11 Colgate-Palmolive Company Method and composition
EP2360165A3 (de) * 2004-03-16 2012-01-04 Boehringer Ingelheim International GmbH Glucopyranosyl-substituierte Benzol-Derivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
UA91546C2 (uk) * 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
US7772191B2 (en) * 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
PE20080697A1 (es) * 2006-05-03 2008-08-05 Boehringer Ingelheim Int Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
CL2008002427A1 (es) * 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
WO2009068617A1 (en) * 2007-11-30 2009-06-04 Boehringer Ingelheim International Gmbh 1, 5-dihydro-pyrazolo (3, 4-d) pyrimidin-4-one derivatives and their use as pde9a modulators for the teatment of cns disorders
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
NZ590788A (en) 2008-09-08 2012-11-30 Boehringer Ingelheim Int Pyrazolopyrimidines and their use for the treatment of cns disorders
BRPI1013640A2 (pt) 2009-02-13 2019-09-24 Boehringer Ingelheim International Gmbh composicao farmaceutica, metodos para o tratamento e usos dos mesmos
WO2010092126A1 (en) * 2009-02-13 2010-08-19 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
CN102307577A (zh) 2009-02-13 2012-01-04 贝林格尔.英格海姆国际有限公司 包含sglt2抑制剂、dpp-iv抑制剂和任选的另一种抗糖尿病药的药物组合物及其用途
PL2414363T3 (pl) 2009-03-31 2014-06-30 Boehringer Ingelheim Int Pochodne 1-heterocyklilo-1,5-dihydro-pirazolo[3,4-d]pirymidyn-4-onu i ich zastosowanie jako modulatorów PDE9A
AR077859A1 (es) * 2009-08-12 2011-09-28 Boehringer Ingelheim Int Compuestos para el tratamiento de trastornos del snc
PT2486029E (pt) * 2009-09-30 2015-10-14 Boehringer Ingelheim Int Processos para a preparação de derivados de benzil-benzeno substituídos com glucopiranosilo
JP5736377B2 (ja) * 2009-09-30 2015-06-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 1−クロロ−4−(β−D−グルコピラノス−1−イル)−2−[4−((S)−テトラヒドロフラン−3−イルオキシ)ベンジル]ベンゼンの結晶形の調製方法
UY32919A (es) * 2009-10-02 2011-04-29 Boehringer Ingelheim Int Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos
DK2603511T3 (en) 2010-08-12 2017-05-08 Boehringer Ingelheim Int 6-CYCLOALKYL-1, 5-DIHYDRO-PYRAZOLO- [3,4-D] PYRIMIDIN-4-ON DERIVATIVES AND THEIR USES AS PDE9A INHIBITORS
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
UY33937A (es) 2011-03-07 2012-09-28 Boehringer Ingelheim Int Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US9192617B2 (en) 2012-03-20 2015-11-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US20140303098A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
HK1213818A1 (zh) 2013-04-05 2016-07-15 勃林格殷格翰国际有限公司 依帕列净的治疗用途
CA2812519A1 (en) 2013-04-05 2014-10-05 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
HUE058731T2 (hu) 2013-04-18 2022-09-28 Boehringer Ingelheim Int Gyógyászati készítmények, kezelési eljárások és ezek alkalmazásai
CN109922813A (zh) 2016-11-10 2019-06-21 勃林格殷格翰国际有限公司 药物组合物、治疗方法及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2544826A (en) * 1945-05-08 1951-03-13 Dow Chemical Co Anthelmintic feed composition
US2615052A (en) * 1950-06-23 1952-10-21 Allied Lab Inc 2,2'-methylenebis(4-chloro-6-nitrophenol) and a method for its production
US2739941A (en) * 1952-09-13 1956-03-27 Gen Aniline & Film Corp Germicidal soap composition
NL283922A (en:Method) * 1962-10-03

Also Published As

Publication number Publication date
BE781674A (fr) 1972-10-05
AU459272B2 (en) 1975-03-05
JPS5950645B2 (ja) 1984-12-10
SU580828A3 (ru) 1977-11-15
SE389331B (sv) 1976-11-01
HU165790B (en:Method) 1974-11-28
FR2132788B1 (en:Method) 1976-05-14
GB1346266A (en) 1974-02-06
FR2132788A1 (en:Method) 1972-11-24
IL39108A0 (en) 1972-05-30
CH575372A5 (en:Method) 1976-05-14
AU4085072A (en) 1973-10-11
DE2215409A1 (de) 1973-01-25
DE2215409C3 (de) 1980-10-09
NL167151B (nl) 1981-06-16
DK143227B (da) 1981-07-27
AR193590A1 (es) 1973-04-30
ES401501A1 (es) 1975-02-16
IE36209L (en) 1972-10-09
PH15268A (en) 1982-11-02
IL39108A (en) 1976-04-30
JPS5525177B1 (en:Method) 1980-07-04
IE36209B1 (en) 1976-09-15
DK143227C (da) 1981-11-30
NL167151C (nl) 1981-11-16
PH14191A (en) 1981-03-26
JPS557256A (en) 1980-01-19
US3884906A (en) 1975-05-20
AR194587A1 (es) 1973-07-31
DE2215409B2 (de) 1980-02-14
NL7104839A (en:Method) 1972-10-11
ZA722331B (en) 1973-01-31

Similar Documents

Publication Publication Date Title
DK129219C (en:Method)
FR2132788B1 (en:Method)
DE2165470B2 (en:Method)
DK137469C (en:Method)
CS163796B2 (en:Method)
DK136887C (en:Method)
DK134543C (en:Method)
DK141722C (en:Method)
FR2089283A5 (en:Method)
FR2121716B3 (en:Method)
FR2122061A5 (en:Method)
FR2090522A5 (en:Method)
FR2122013A5 (en:Method)
FR2121519B1 (en:Method)
DK138986C (en:Method)
FR2095189B2 (en:Method)
DK139518C (en:Method)
CS157877B1 (en:Method)
CS162881B1 (en:Method)
DE2156394A1 (en:Method)
CS170278B1 (en:Method)
CS157250B1 (en:Method)
CS171338B1 (en:Method)
DD96458A1 (en:Method)
DD108506A5 (en:Method)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased